Early Detection & Diagnosis

grbbfrfhfggjfgjkjnvfvnfgdmm,mnnm b bn n mnmnmnmn bvfgghjhjjkllk;

A patient came to Color with a pancreatic cancer diagnosis from their treating provider. After reviewing the case through our tumor board, to assess the diagnosis. Our clinicians identified that the diagnosis was incorrect. It was instead, cholangiocarcinoma, or bile duct cancer, a different disease requiring a completely different treatment plan, prognosis, and clinical trial options.

Because a partnership had been built with the treating provider from day one, Color caught the error before therapy began, avoided unnecessary treatment, and moved the patient quickly into the right care.

A woman with dense breast tissue went through the standard prior authorization and appeal process for an MRI, but the clinical documentation did not fully capture the nuances of her risk. She reached out to Color for help understanding her next steps. Our oncologists reviewed her history, completed the necessary risk calculations, and submitted additional clinical details to her health plan as part of the ongoing appeal. With the full context in place, the plan approved the MRI and she advanced quickly into follow-up care.

A patient hadn't seen a doctor in more than 20 years when she enrolled with Color. During her clinical assessment, our team identified high-risk symptoms that required urgent attention.

Color immediately escalated her to diagnostic imaging, ordered a full workup including biopsy and specialist referral, and confirmed a breast cancer diagnosis in just 18 days, compared to the six-month national average.